1. Home
  2. CVKD vs NWGL Comparison

CVKD vs NWGL Comparison

Compare CVKD & NWGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVKD
  • NWGL
  • Stock Information
  • Founded
  • CVKD 2022
  • NWGL 2008
  • Country
  • CVKD United States
  • NWGL Macau
  • Employees
  • CVKD N/A
  • NWGL N/A
  • Industry
  • CVKD Medicinal Chemicals and Botanical Products
  • NWGL
  • Sector
  • CVKD Health Care
  • NWGL
  • Exchange
  • CVKD Nasdaq
  • NWGL Nasdaq
  • Market Cap
  • CVKD 27.0M
  • NWGL 22.8M
  • IPO Year
  • CVKD 2023
  • NWGL 2023
  • Fundamental
  • Price
  • CVKD $14.13
  • NWGL $1.74
  • Analyst Decision
  • CVKD Strong Buy
  • NWGL
  • Analyst Count
  • CVKD 1
  • NWGL 0
  • Target Price
  • CVKD $32.00
  • NWGL N/A
  • AVG Volume (30 Days)
  • CVKD 25.8K
  • NWGL 19.1K
  • Earning Date
  • CVKD 11-07-2025
  • NWGL 11-29-2025
  • Dividend Yield
  • CVKD N/A
  • NWGL N/A
  • EPS Growth
  • CVKD N/A
  • NWGL N/A
  • EPS
  • CVKD N/A
  • NWGL N/A
  • Revenue
  • CVKD N/A
  • NWGL $21,539,347.00
  • Revenue This Year
  • CVKD N/A
  • NWGL N/A
  • Revenue Next Year
  • CVKD N/A
  • NWGL N/A
  • P/E Ratio
  • CVKD N/A
  • NWGL N/A
  • Revenue Growth
  • CVKD N/A
  • NWGL N/A
  • 52 Week Low
  • CVKD $8.74
  • NWGL $0.91
  • 52 Week High
  • CVKD $22.90
  • NWGL $6.61
  • Technical
  • Relative Strength Index (RSI)
  • CVKD 54.38
  • NWGL 61.56
  • Support Level
  • CVKD $12.11
  • NWGL $1.40
  • Resistance Level
  • CVKD $14.35
  • NWGL $1.53
  • Average True Range (ATR)
  • CVKD 0.66
  • NWGL 0.11
  • MACD
  • CVKD -0.08
  • NWGL 0.01
  • Stochastic Oscillator
  • CVKD 76.99
  • NWGL 89.74

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

About NWGL Nature Wood Group Limited

Nature Wood Group Ltd is a vertically-integrated forestry company that focuses on FSC business operations. It produces various products, including logs, decking, flooring, sawn timber, recycled charcoal, synthesized charcoal, machine-made charcoal, and essential oils. The Group owns natural forest concessions and cutting rights for exploiting timbers on parcels of land in Peru. The Group is organized into two operating divisions; Direct Purchase and Original Design Manufacturer (ODM) Services, and Manufacturing segments. The Direct Purchase and ODM Segment that derives the majority of revenue engages in the business of sourcing live wood and owning designed designs on wood products for sales to end customers. Geographically, the company generates a majority of its revenue from China.

Share on Social Networks: